Aiff H, Attman PO, Aurell M, Bendz H, Schön S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014;24(4):540–4.

Article  CAS  PubMed  Google Scholar 

Baethge C, Tondo L, Bratti IM, Bschor T, Bauer M, Viguera AC, Baldessarini RJ. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry. 2003;48(7):449–57.

Article  PubMed  Google Scholar 

Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, et al. Onset-age of bipolar disorders at six international sites. J Affect Disord. 2010;121(1–2):143–6.

Article  CAS  PubMed  Google Scholar 

Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, et al. Predictors and the subsequent risk of end-stage renal disease—usefulness of 30% decline in estimated GFR over 2 Years. PLoS ONE. 2015;10(7): e0132927.

Article  PubMed  PubMed Central  Google Scholar 

Close H, Reilly J, Mason JM, Kripalani M, Wilson D, Main J, Hungin AP. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS ONE. 2014;9(3): e90169.

Article  PubMed  PubMed Central  Google Scholar 

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–31.

Article  PubMed  PubMed Central  Google Scholar 

Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–80.

Article  PubMed  PubMed Central  Google Scholar 

Dastych M, Synek O, Gottwaldová J. Impact of long-term lithium treatment on renal function in patients with bipolar disorder based on novel biomarkers. J Clin Psychopharmacol. 2019;39(3):238–42.

Article  CAS  PubMed  Google Scholar 

Diflorio A, Jones I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry. 2010;22(5):437–52.

Article  PubMed  Google Scholar 

Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69(2):375–82.

Article  CAS  PubMed  Google Scholar 

Golic M, Aiff H, Attman PO, Ramsauer B, Schön S, Steingrimsson S, Svedlund J. Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study. Int J Bipolar Disord. 2023;11(1):39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, et al. Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data. J Am Soc Nephrol. 2019;30(9):1746–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, et al. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant. 2010;25(3):801–7.

Article  PubMed  Google Scholar 

Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, et al. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. Am J Kidney Dis. 2014;64(6):848–59.

Article  PubMed  Google Scholar 

Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, et al. GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials. J Am Soc Nephrol. 2019;30(9):1735–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study. Clin Exp Nephrol. 2018;22(2):318–27.

Article  PubMed  Google Scholar 

Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, et al. Past decline versus current eGFR and subsequent ESRD Risk. J Am Soc Nephrol. 2016;27(8):2447–55.

Article  PubMed  Google Scholar 

Lambers Heerspink HJ, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, et al. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis. 2014a;64(6):860–6.

Article  PubMed  Google Scholar 

Lambers Heerspink HJ, Weldegiorgis M, Inker LA, Gansevoort R, Parving HH, Dwyer JP, et al. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the reduction of end points in non-insulin-dependent diabetes with the angiotensin II antagonist losartan (RENAAL) study and Irbesartan diabetic nephropathy trial (IDNT). Am J Kidney Dis. 2014b;63(2):244–50.

Article  CAS  PubMed  Google Scholar 

Larsson S, Lorentzen S, Mork E, Barrett EA, Steen NE, Lagerberg TV, et al. Age at onset of bipolar disorder in a Norwegian catchment area sample. J Affect Disord. 2010;124(1–2):174–7.

Article  PubMed  Google Scholar 

Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the national kidney foundation and the US food and drug administration. Am J Kidney Dis. 2014;64(6):821–35.

Article  PubMed  Google Scholar 

Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Cheung M, Jadoul M, Winkelmayer WC. Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference. Nephrol Dial Transplant. 2020;35(7):1077–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, et al. Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int. 2016;90(5):1109–14.

Article  PubMed  Google Scholar 

McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–8.

Article  CAS  PubMed  Google Scholar 

Meguro S, Inaishi J, Sato Y, Komuro I, Itoh H. One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patients. J Diabetes Investig. 2021;12(7):1212–9.

Article  CAS  PubMed  Google Scholar 

Miyakoshi T, Nakasone Y, Sato Y, Yamauchi K, Hashikura R, Takayama M, et al. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects. Nephrology (Carlton). 2017;22(9):684–9.

Article  CAS  PubMed  Google Scholar 

O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–65.

Article  PubMed  Google Scholar 

Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, et al. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLoS ONE. 2018;13(8): e0201535.

Article  PubMed  PubMed Central  Google Scholar 

Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, et al. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Diabetologia. 2019;62(11):1988–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oshima M, Toyama T, Hara A, Shimizu M, Kitajima S, Iwata Y, et al. Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e002311.

Article  PubMed  PubMed Central  Google Schola